R Caruso, F Alesiani, R Latagliata. Prolonged low doses of oral etoposide may be effective in individual patients with advanced lymphoproliferative disorders refractory to aggressive chemotherapy. Haematologica 1997;82(1):126-127; https://doi.org/10.3324/%x.